Kolexia
Coutant Frederic
Biologie médicale
Hôpital Lyon Sud
Pierre-Bénite, France
42 Activités
238 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Polyarthrite rhumatoïde Arthrite Myosite Dermatomyosite Maladies musculaires COVID-19 Maladies auto-immunes Pneumopathies interstitielles Lymphome T

Industries

B3TSI
15 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
11 collaboration(s)
Dernière en 2023
BMS
3 collaboration(s)
Dernière en 2022
Pfizer
1 collaboration(s)
Dernière en 2022

Dernières activités

Neutralizing and Enhancing Monoclonal Antibodies in SARS-CoV-2 Convalescent Patients: Lessons from Early Variant Infection and Impact on Shaping Emerging Variants.
Emerging microbes & infections   19 janvier 2024
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies.
Autoimmunity reviews   23 août 2023
Detection of anti-eIF2B autoantibodies in systemic sclerosis by immunoprecipitation-mass spectrometry.
Rheumatology (Oxford, England)   07 juillet 2023
Serum Col3-4: A new type III and IV collagen biochemical marker of synovial tissue turnover in patients with rheumatoid arthritis.
PloS one   13 avril 2023
Mass spectrometry-based identification of new anti-Ly and known antisynthetase autoantibodies.
Annals of the rheumatic diseases   26 décembre 2022
Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study.
Biomedicines   08 décembre 2022
Evaluation of the Performance of an Indirect Immunofluorescence Assay for the Detection of Anti-MDA5 Antibodies.
Biomedicines   18 novembre 2022
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production.
Journal of autoimmunity   15 avril 2022
Shaping of Monocyte-Derived Dendritic Cell Development and Function by Environmental Factors in Rheumatoid Arthritis.
International journal of molecular sciences   20 décembre 2021
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.
Frontiers in immunology   20 octobre 2021